These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 23688540)

  • 61. Community pharmacists' attitudes towards medicines use reviews and factors affecting the numbers performed.
    Latif A; Boardman H
    Pharm World Sci; 2008 Oct; 30(5):536-43. PubMed ID: 18288585
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of community pharmacist-performed post-discharge medication reviews in transitions of care.
    Tetuan CE; Guthrie KD; Stoner SC; May JR; Hartwig DM; Liu Y
    J Am Pharm Assoc (2003); 2018; 58(6):659-666. PubMed ID: 30056133
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A qualitative evaluation of a health literacy intervention to improve medication adherence for underserved pharmacy patients.
    Blake SC; McMorris K; Jacobson KL; Gazmararian JA; Kripalani S
    J Health Care Poor Underserved; 2010 May; 21(2):559-67. PubMed ID: 20453356
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identifying drug-related problems during transition between secondary and primary care in New Zealand.
    Maxwell K; Harrison J; Scahill S; Braund R
    Int J Pharm Pract; 2013 Oct; 21(5):333-6. PubMed ID: 23418995
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study.
    Quintana-Bárcena P; Lalonde L; Lauzier S
    Res Social Adm Pharm; 2019 Feb; 15(2):145-153. PubMed ID: 29709530
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
    Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.
    Ali MAS; Khedr EMH; Ahmed FAH; Mohamed NNE
    Int J Clin Pharm; 2018 Oct; 40(5):1257-1264. PubMed ID: 29922968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs).
    Viktil KK; Blix HS; Moger TA; Reikvam A
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):667-74. PubMed ID: 16598835
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improved adherence with Medicines Use Review service in Slovenia: a randomized controlled trial.
    Nabergoj Makovec U; Locatelli I; Kos M
    BMC Health Serv Res; 2021 Mar; 21(1):266. PubMed ID: 33752647
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of the pharmaceutical case management program implemented in a private sector health plan.
    Witry MJ; Doucette WR; Gainer KL
    J Am Pharm Assoc (2003); 2011; 51(5):631-5. PubMed ID: 21896463
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Factors influencing the provision of adherence support by community pharmacists: A structural equation modeling approach.
    Mansoor SM; Krass I; Costa DS; Aslani P
    Res Social Adm Pharm; 2015; 11(6):769-83. PubMed ID: 25749550
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
    Emmerton L
    J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug-related problems identified during geriatric medication review in the community pharmacy.
    Rhalimi M; Rauss A; Housieaux E
    Int J Clin Pharm; 2018 Feb; 40(1):109-118. PubMed ID: 29188412
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.
    Covert KL; Mardis CR; Fleming JN; Pilch NA; Meadows HB; Mardis BA; Mohan P; Posadas-Salas M; Srinivas T; Taber DJ
    Pharmacotherapy; 2017 Feb; 37(2):159-169. PubMed ID: 27997676
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Community pharmacists' perceptions of medicines use reviews and quality assurance by peer review.
    Harding G; Wilcock M
    Pharm World Sci; 2010 Jun; 32(3):381-5. PubMed ID: 20349274
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China.
    Chen Q; Jin Z; Zhang P; Sun S; Li L; Liao Y
    Int J Clin Pharm; 2020 Aug; 42(4):1237-1241. PubMed ID: 32607718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.